According to the Associated Press, the FDA pushed drugmakers to warn
against using the OTC drugs in young children. And the four-year-old cut-off
appears to have been a compromise proposed by FDA in behind-the-scenes talks
with the companies involved. …
“There are other tools out there that can integrate stuff, but the unique aspect
of IGV at the moment is how we handle the problem of volume by just serving up
little pieces as you need them,” …
Peter Breggin, M.D. author Medication Madness
Bruce Levine, Ph.D.
clinical psychologist
Dominick Riccio, Ph.D. Psychologist &
psychoanalyst
James B. Gottstein, attorney …
“We are working on making sure only pancreatic cancer cells see this suicide
gene,” Brody says. “By this, we are putting tighter regulation on the expression
of this toxic gene. We hope to just help pancreatic cancer patients.” …
The Harlem DNA Lab is the result of a collaboration between the New York City
Department of Education and Cold Spring Harbor Laboratory. …
The festival kicks off on Oct. 16 with “Science in Fiction,” a panel discussion
on the relationship between science and fiction in cinema, moderated by NPR’s
Science Friday host Ira Flatow. The festival will show 24 shorts in competition,
and several feature films. All screenings are free of charge. …
Green fluorescent protein (GFP) has won its discoverer and early developers the
2008 Nobel Prize in Chemistry. …
According to a new Datamonitor report, cash-rich drugmakers are poised to take
advantage of the credit crunch, in part because they didn’t
overdose on the cheap debt that has trapped so many companies now that credit
has dried up. …
The Neurontin accusations emerge at a time when more and more drugmakers have
come under scrutiny for their handling of research data. …
One of the big questions posed by the development of new genetic tests is how
people will react when they learn more about their risk of disease. …